Logo

Call us today 212-583-0100

ir@enzo.com    

  • Home
  • Corporate
    • Investor Information
    • About Us
    • Officers & Directors
    • Press Releases
    • Careers
  • Therapeutics
    • About ENZO Therapeutics
      • Overview
      • Our Mission
      • Our Strategy
      • Partnering
      • Maps and Directions
      • Contact Us
    • Therapeutic Market
      • Overview
      • Inflammatory Bowel Disease
      • Uveitis
      • HIV
      • Bone Disorders
      • Diabetes
    • Technologies
      • Immune Regulation
      • Gene Technology
      • Cell Signaling Modulation
    • Pipeline
      • Overview
      • Cell Signaling Modulation
        • Diabetes
        • Preclinical Studies for Bone Disorders
      • Immune Regulation
        • Alequel ™
        • Optiquel ™
      • Gene Technology
        • Stealth Vector™ HGTV43™
  • Clinical Labs
  • Life Sciences
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jun 29, 2017 8:00am EDT

Enzo Biochem Reports Delaware Court Ruling

Jun 08, 2017 4:10pm EDT

Enzo Biochem Reports Increased Revenues, Improved Operating Results

Jun 08, 2017 4:00pm EDT

Enzo Biochem Announces New York State Health Department Approval of New Women’s Health Diagnostics

Jun 02, 2017 10:00am EDT

Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2017 Results Friday, June 9, 2017 at 8:30 AM E.T.

Apr 17, 2017 8:30am EDT

Enzo Biochem’s Clinical Laboratory Named an In-Network Provider to the Fourth Largest National Insurer

Mar 13, 2017 4:05pm EDT

Enzo Biochem Reports Increased Second Quarter Operating Results

Mar 13, 2017 12:16pm EDT

Enzo Biochem Re-Schedules Teleconference to Discuss Second Quarter 2017 Results for This Afternoon, Monday, March 13, 2017 at 4:30 PM E.D.T. Due to Impending Storm

Mar 06, 2017 10:30am EST

Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2017 Results Tuesday, March 14, 2017 at 8:30 AM E.T.

Dec 08, 2016 4:05pm EST

Enzo Biochem Reports Improved First Quarter Results

Dec 01, 2016 3:39pm EST

Enzo Biochem Schedules Teleconference to Discuss First Quarter 2017 Results Friday, December 9, 2016 at 8:30 AM E.T.

  • Previous
  • 1…
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …32
  • Next
RSS
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Meta

  • Privacy Policy
  • Intellectual Property
  • Safe Harbor Statement
  • HIPAA Policy
  • Web Feedback

Contact us

Enzo Biochem Executive Offices
81 Executive Blvd, Suite 3
Farmingdale, NY
11735
USA

212-583-0100

info@enzo.com

Copyright ©2023 Enzo Biochem Inc.